MedPath

Puerarin Effects on Alcohol Drinking

Phase 2
Completed
Conditions
Alcohol Abuse
Interventions
Drug: Puerarin, Placebo
Registration Number
NCT00854724
Lead Sponsor
Mclean Hospital
Brief Summary

This research is designed to assess the impact of pretreatment with puerarin (NPI-031G), a major ingredient in the plant kudzu, on alcohol drinking. Hypothesis: Short-term treatment with this compound will reduce alcohol self-administration in a simulated natural settings laboratory.

Detailed Description

Participants will have an opportunity to drink up to 6 beers, plus water and juice, during a 90 minute afternoon drinking session in our simulated apartment room laboratory. Drinking sessions will be conducted in the afternoon after participants take puerarin or placebo for 7 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • moderate to heavy alcohol drinkers (20+ drinks per week)
Exclusion Criteria
  • alcohol dependence or treatment-seeking drinkers
  • other drug abuse or dependence
  • psychiatric disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PuerarinPuerarin, Placebo-
PlaceboPuerarin, PlaceboSugar beet filler in capsule
Primary Outcome Measures
NameTimeMethod
Amount of Alcohol ConsumedDuring a 90 minute drinking session
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

McLean Hospital, Behavioral Psychopharmacology Research Laboratory

🇺🇸

Belmont, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath